Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
europe blog main
3
×
europe top stories
fda
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
deals
deerfield management
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
What
ipo
3
×
bio
covid
medicines
new
roundup
acquisitions
activity
announced
approvals
arrival
biogen
biotech
ceo
clamped
collabs
companies
daniel
days
deal
delays
developing
economic
fast
fda
gilead
gilead’s
hasn’t
help
including
industry
introduce
ipos
isn’t
life
lot
market
momentum
month
oric’s
Language
unset
Current search:
ipo
×
national
×
" europe blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More